Trials / Completed
CompletedNCT06974045
Impact of COVID-19 Pandemic on Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service
Evaluation of a Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service Pre-, Intra- and Post-COVID-19 Pandemic: a Retrospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 237 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Choledocholithiasis is reported to be present in 15-20% of patients with symptomatic gallstones. The single-stage management consists of performing either laparoscopic common bile duct exploration (LCBDE) or intraoperative endoscopic retrograde cholangiopancreatography (ERCP) at the same time as laparoscopic cholecystectomy (LC). Since the Coronavirus (COVID-19) pandemic, surgical practice has significantly been impacted. The pandemic has had ramifications on patient and staff safety, surgical techniques, minimally invasive procedures, theatre workflow, education and training. The investigators analysed a series of LCBDE procedures in our institution pre-, intra- and post-COVID-19 pandemic to assess the feasibility, efficacy and safety of this single-stage treatment approach following the pandemic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Single-stage LC + LCBDE | Choledochotomy and transductal common bile duct exploration or transcystic choledochoscopy and common bile duct exploration |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2024-02-01
- Completion
- 2025-05-01
- First posted
- 2025-05-15
- Last updated
- 2026-03-27
Source: ClinicalTrials.gov record NCT06974045. Inclusion in this directory is not an endorsement.